CLOUGH CAPITAL PARTNERS L P - CORREVIO PHARMA CORP ownership

CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 31 filers reported holding CORREVIO PHARMA CORP in Q4 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.

Quarter-by-quarter ownership
CLOUGH CAPITAL PARTNERS L P ownership history of CORREVIO PHARMA CORP
ValueSharesWeighting
Q3 2019$4,114,000
-8.6%
2,057,124
-1.3%
0.34%
-23.1%
Q2 2019$4,503,000
-32.5%
2,084,824
-1.3%
0.44%
-24.2%
Q1 2019$6,671,000
+12.9%
2,111,224
-11.0%
0.58%
-16.0%
Q4 2018$5,907,000
-31.3%
2,372,224
+10.9%
0.69%
-14.4%
Q3 2018$8,600,000
+10.3%
2,139,294
+3.7%
0.81%
+16.5%
Q2 2018$7,795,0002,062,2630.70%
Other shareholders
CORREVIO PHARMA CORP shareholders Q4 2019
NameSharesValueWeighting ↓
SUMMER ROAD LLC 250,000$103,0000.68%
Tamarack Advisers, LP 2,500,000$1,019,0000.23%
Virtu Financial LLC 287,972$118,0000.01%
ARS Investment Partners, LLC 147,818$61,0000.01%
Pacifica Partners Inc. 2,665$1,0000.00%
OXFORD ASSET MANAGEMENT LLP 116,653$48,0000.00%
K.J. Harrison & Partners Inc 12,860$5,0000.00%
TORONTO DOMINION BANK 153$00.00%
SCOTIA CAPITAL INC. 19,000$8,0000.00%
MORGAN STANLEY 99,852$41,0000.00%
View complete list of CORREVIO PHARMA CORP shareholders